NexMed Receives FDA Non Approvable Letter for ED Product - News ...
23 Jul 2008 ... The major regulatory issues raised by the FDA were related to the results of the transgenic mouse carcinogenicity study which NexMed ...
http://www.biospace.com/news_story.aspx?NewsEntityId=104194...
|
BioPortfolio - NexMed
NexMed - Entry on Bioportfolio's Biocorporate Database.
http://www.bioportfolio.com/biocorporate/7520-NexMed.html...
|
Warner Chilcott and NexMed Sign U.S. Collaboration for Topical ...
2 Nov 2007 ... NexMed submitted a New Drug Application with the Food and Drug Administration on September 21, 2007 and is awaiting confirmation of ...
http://www.biospace.com/news_story.aspx?NewsEntityId=75916...
|
NexMed Approved to Sell N.J. Tax Credits: Financial News - Yahoo ...
NexMed Approved to Sell NJ Tax Credits. - EAST WINDSOR, NJ--(BUSINESS WIRE)-- NexMed, Inc. (Nasdaq: NEXM - News), a developer of innovative products based on
...
http://biz.yahoo.com/bw/081118/20081118005549.html?.v=1...
|
NexMed Says It Will Not File NDA for Nail Drug - News, Search Jobs ...
NexMed entered into an exclusive, worldwide agreement with Novartis in September 2005, under which Novartis assumed all clinical development, regulatory, ...
http://www.biospace.com/news_story.aspx?NewsEntityId=107949...
|
NexMed Discusses End of Review Meeting for Vitaros(R): Financial ...
NexMed Discusses End of Review Meeting for Vitaros(R). - EAST WINDSOR, NJ--( BUSINESS WIRE)--NexMed, Inc. (Nasdaq: NEXM - News), a developer of innovative
...
http://biz.yahoo.com/bw/081020/20081020005458.html?.v=1...
|
{1} Announces IND Filing Of InnoNyx(TM) For Nail Fungal Infection ...
Ken Anderson, NexMed's Vice President for Commercial Development, ... NexMed, Inc. is an emerging drug developer that is leveraging its proprietary drug ...
http://www.biospace.com/news_story.aspx?NewsEntityId=1748072...
|
NexMed Announces $3.5 Million Milestone Payment: Financial News ...
NexMed Announces $3.5 Million Milestone Payment. - EAST WINDSOR, NJ--(BUSINESS WIRE)--NexMed, Inc. (Nasdaq: NEXM - News), a developer of products based on ...
http://biz.yahoo.com/bw/081027/20081027005262.html?.v=1...
|
{1} Announces Patent Allowance For Room Temperature Stable Alprox ...
9 Nov 2004 ... Dr. Y. Joseph Mo, President and C.E.O. of NexMed, commented, "We are very excited by this patent allowance since it covers the next ...
http://www.biospace.com/news_story.aspx?NewsEntityId=1790542...
|
NexMed Receives NASDAQ Listing Qualifications Letter: Financial ...
NexMed Receives NASDAQ Listing Qualifications Letter. - EAST WINDSOR, NJ--( BUSINESS WIRE)--NexMed, Inc. (Nasdaq: NEXM - News), a developer of innovative
...
http://biz.yahoo.com/bw/081013/20081013005312.html?.v=1...
|
